Industry News
Circadian owns Vegenics
Circadian finalises Vegenics purchase [ + ]
Biotron expands HCV trial
Biotron adds Brisbane site for hep C clinical trial [ + ]
Next trial for Starpharma
Starpharma studies VivaGel duration [ + ]
Colman wins Victoria Prize
WEHI's Peter Colman wins Victoria's top science prize [ + ]
CSL profit up 30pc, to outlay $3.5b for Talecris
CSL reports massive earnings, agrees to buy US plasma business Talecris [ + ]
Clean air for Pharmaxis
Pharmaxis concludes dose study of Bronchitol in cystic fibrosis patients [ + ]
Patched and the cell of origin battle
Researchers answer brain tumour 'cell of origin' question [ + ]
Another win for CogState
CogState wins $1.2 million technology contract [ + ]
Acrux simplifies KV deal
Acrux expands partnership agreement with KV Pharmaceuticals [ + ]
Cochlear profit up
Cochlear records 15% profit growth [ + ]
Knees next for Mesoblast
Mesoblast's stem cells able to regenerate damaged knee cartilage [ + ]
Welcome biotech funds for Victoria
New funding announced in Victorian innovation statement [ + ]
Growth for Tissue Therapies
Tissue Therapies begins first trial in patient with venous ulcer [ + ]
Biota targets the sniffles
Biota begins dosing in early stage cold preventative [ + ]
